Cytotoxic immune response after retroviral-mediated hepatic gene transfer in rat does not preclude expression from adeno-associated virus 1 transduced muscles

Human Gene Therapy

Volumn 14, Issue 5, 2003, Pages 473-481

  Aubert, Dominique ^a   Pichard, Virginie ^a   Durand, Sophie ^a   Moullier, Philippe ^a   Ferry, Nicolas ^a,b  

^a INSERM   (France)

^b HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; GENE PRODUCT; RETROVIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; GENE TRANSFER; GENETIC TRANSDUCTION; IMMUNE RESPONSE; IMMUNIZATION; LIVER CELL; LIVER RESECTION; MALE; MUSCLE; MUSCLE CELL; NONHUMAN; PROTEIN EXPRESSION; RAT; RETROVIRUS; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRUS EXPRESSION; VIRUS IMMUNITY;

ANIMALS; BETA-GALACTOSIDASE; CELL LINE; DEPENDOVIRUS; GENE EXPRESSION; GENES, REPORTER; GENETIC VECTORS; HEPATECTOMY; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; LIVER; MALE; MUSCLE, SKELETAL; POLYMERASE CHAIN REACTION; RATS; RATS, WISTAR; RETROVIRIDAE; T-LYMPHOCYTES, CYTOTOXIC; TRANSDUCTION, GENETIC;

ADENO-ASSOCIATED VIRUS; ADENO-ASSOCIATED VIRUS 1; ANIMALIA; DNA VIRUSES; UNIDENTIFIED RETROVIRUS;

EID: 0037457011     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303403321467234     Document Type: Article

References (39)

1. ANDO, K., GUIDOTTI, L.G., CERNY, A., ISHIKAWA, T., and CHISARI, F.V. (1994). CTL access to tissue antigen is restricted in vivo. J. Immunol. 153, 482-488.
2. AUBERT, D., MENORET, S., CHIARI, E., PICHARD, V., DURAND, S., TESSON, L., MOULLIER, P., ANEGON, I., and FERRY, N. (2002). Cytotoxic immune response blunts long-term transgene expression after efficient retroviral-mediated hepatic gene transfer in rat. Mol. Ther. 5, 388-396.
3. BRALET, M.P., BRANCHEREAU, S., BRECHOT, C., and FERRY, N. (1994). Cell lineage study in the liver using retroviral mediated gene transfer: Evidence against the streaming of hepatocytes in normal liver. Am. J. Pathol. 144, 896-905.
4. CAI, S.R., KENNEDY, S.C., BOWLING, W.M., FLYE, M.W., and PONDER, K.P. (1998). Therapeutic levels of human protein C in rats after retroviral vector- mediated hepatic gene therapy. J. Clin. Invest. 101, 2831-2841.
5. COSSET, F.L., TAKEUCHI, Y., BATTINI, J.L., WEISS, R.A., and COLLINS, M.K.L. (1995). High-titer packaging cells producing recombinant retroviruses resistant to human serum. J. Virol. 69, 7430-7436.
6. DE GODOY, J.L., MALAFOSSE, R., FABRE, M., MEHTALI, M., HOUSSIN, D., and SOUBRANE, O. (1999). In vivo hepatocyte retrovirus-mediated gene transfer through the rat biliary tract. Hum. Gene Ther. 10, 249-257.
7. DUNCKLEY, M.G., WELLS, D.J., WALSH, F.S., and DICKSON, G. (1993). Direct retroviral-mediated transfer of a dystrophin minigene into mdx mouse muscle in vivo. Hum. Mol. Genet. 2, 717-723.
8. FAVRE, D., CHEREL, Y., PROVOST, N., BLOUIN, V., FERRY, N., MOULLIER, P., and SALVETTI, A. (2000). Hyaluronidase enhances recombinant adeno-associated virus (rAAV)-mediated gene transfer in the rat skeletal muscle. Gene Ther. 7, 1417-1420.
9. FIELDS, P.A., KOWALCZYK, D.W., ARRUDA, V.R., ARMSTRONG, E., MCCLELAND, M.L., HAGSTROM, J.N., PASI, K.J., ERTL, H.C., HERZOG, R.W., and HIGH, K.A. (2000). Role of vector in activation of T cell subsets in immune responses against the secreted transgene product factor IX. Mol. Ther. 1, 225-235.
10. GAO, C., SANDS, M.S., HASKINS, M.E., and PONDER, K.P. (2000). Delivery of a retroviral vector expressing human beta-glucuronidase to the liver and spleen decreases lysosomal storage in mucopolysaccharidosis VII mice. Mol. Ther. 2, 233-244.
11. GRIMM, D., KERN, A., RITTNER, K., and KLEINSCHMIDT, J.A. (1998). Novel tools for production and purification of recombinant adeno-associated virus vectors. Hum. Gene Ther. 9, 2745-2760.
12. HERZOG, R.W., YANG, EY., COUTO, L.B., HAGSTROM, J.N., ELWELL, D., FIELDS, P.A., BURTON, M., BELLINGER, D.A., READ, M.S., BRINKHOUS, K.M., PODSAKOFF, G.M., NICHOLS, T.C., KURTZMAN, G.J., and HIGH, K.A. (1999). Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector. Nat. Med. 5, 56-63.
13. HIGGINS, G.M., and ANDERSON, R.M. (1931). Experimental pathology of the liver I. Restoration of the liver of the white rat following partial surgical removal. Arch. Pathol. 12, 186-202.
14. IRWIN, M.J., LAUBE, L.S., LEE, V., AUSTIN, M., CHADA, S., ANDERSON, C.G., TOWNSEND, K., JOLLY, D.J., and WARNER, J.F. (1994). Direct injection of a recombinant retroviral vector induces human immunodeficiency virus-specific immune responses in mice and nonhuman primates. J. Virol. 68, 5036-5044.
15. IZEMBART, A., AGUADO, E., GAUTHIER, O., AUBERT, D., MOULLIER, P., and FERRY, N. (1999). In vivo retrovirus-mediated gene transfer to the liver of dogs results in transient expression and induction of a cytotoxic immune response. Hum. Gene Ther. 10, 2917-2925.
16. JOOSS, K., ERTL, H.C., and WILSON, J.M. (1998a). Cytotoxic T-lymphocyte target proteins and their major histocompatibility complex class I restriction in response to adenovirus vectors delivered to mouse liver. J. Virol. 72, 2945-2954.
17. JOOSS, K., YANG, Y., FISHER, K.J., and WILSON, J.M. (1998b). Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers. J. Virol. 72, 4212-4223.
18. KAY, M.A., LI, Q., LIU, T., LELAND, F., TOMAN, C., FINEGOLD, M., and WOO, S.L.C. (1992). Hepatic gene therapy: Persistent expression of human alpha 1 antitrypsin in mice after direct gene delivery in vivo. Hum. Gene Ther. 3, 641-647.
19. KAY, M.A., ROTHENBERG, S., LANDEN, C.N., BELLINGER, D.A., LELAND, F., TOMAN, C., FINEGOLD, M., THOMPSON, A.R., READ, M.S., BRINKHOUS, K.M., and WOO, S.L.C. (1993). In vivo gene therapy of hemophilia-B-sustained partial correction in factor-IX-deficient dogs. Science 262, 117-119.
20. KITTEN, O., COSSET, F.L., and FERRY, N. (1997). Highly efficient retrovirus-mediated gene transfer into rat hepatocytes in vivo. Hum. Gene Ther. 8, 1491-1494.
21. LE, M., OKUYAMA, T., CAI, S.R., KENNEDY, S.C., BOWLING, W.M., FLYE, M.W., and PONDER, K.P. (1997). Therapeutic levels of functional human factor X in rats after retroviral-mediated hepatic gene therapy. Blood 89, 1254-1259.
22. MANNING, W.C., PALIARD, X., ZHOU, S., PAT BLAND, M., LEE, A.Y., HONG, K, WALKER, C.M., ESCOBEDO, J.A., and DWARKI, V. (1997). Genetic immunization with adeno-associated virus vectors expressing herpes simplex virus type 2 glycoproteins B and D. J. Virol. 71, 7960-7972.
23. MENORET, S., AUBERT, D., TESSON, L., BRAUDEAU, C., PICHARD, V., FERRY, N., and ANEGON, I. (2002). lacZ transgenic rats tolerant for β-galactosidase: Recipients for gene transfer studies using lacZ as a reporter gene. Hum. Gene Ther. 13, 1383-1390.
24. NATHWANI, A.C., DAVIDOFF, A., HANAWA, H., ZHOU, J.F., VANIN, E.F., and NIENHUIS, A.W. (2001). Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA. Blood 97, 1258-1265.
25. PINTO, V.B., PRASAD, S., YEWDELL, J., BENNINK, J., and HUGHES, S.H. (2000). Restricting expression prolongs expression of foreign genes introduced into animals by retroviruses. J. Virol. 74, 10202-10206.
26. RETTINGER, S.D., KENNEDY, S.C., WU, X.Y., SAYLORS, R.L., HAFENRICHTER, D.G., FLYE, M.W., and PONDER, K.P. (1994). Liver-directed gene therapy: Quantitative evaluation of promoter elements by using in vivo retroviral transduction. Proc. Natl. Acad. Sci. U.S.A. 91, 1460-1464.
27. SARUKHAN, A., SOUDAIS, C, DANOS, O., and JOOSS, K. (2001). Factors influencing cross-presentation of non-self antigens expressed from recombinant adeno-associated virus vectors. J. Gene Med. 3, 260-270.
28. SNYDER, R.O., MIAO, C., MEUSE, L., TUBB, J., DONAHUE, B.A., LIN, H.F., STAFFORD, D.W., PATEL, S., THOMPSON, A.R., NICHOLS, T., READ, M.S., BELLINGER, D.A., BRINKHOUS, K.M., and KAY, M.A. (1999). Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors. Nat. Med. 5, 64-70.
29. SONG, E.S., LEE, V., SURH, C.D., LYNN, A., BRUMM, D., JOLLY, D.J., WARNER, J.F., and CHADA, S. (1997). Antigen presentation in retroviral vector-mediated gene transfer in vivo. Proc. Natl. Acad. Sci. U.S.A. 94, 1943-1948.
30. TADA, K., CHOWDHURY, N.R., NEUFELD, D., BOSMA, P.J., HEARD, M., PRASAD, V.R., and CHOWDHURY, J.R. (1998). Long-term reduction of serum bilirubin levels in Gunn rats by retroviral gene transfer in vivo. Liver Transplant. Surg. 4, 78-88.
31. THOMASON, D.B., and BOOTH, F.W. (1990). Stable incorporation of a bacterial gene into adult rat skeletal muscle in vivo. Am. J. Physiol. 258, C578-581.
32. TOWNSEND, K., SALLBERG, M., O'DEA, J., BANKS, T., DRIVER, D., SAUTER, S., CHANG, S.M., JOLLY, D.J., MENTO, S.J., MILICH, D.R., and LEE, W.T. (1997). Characterization of CD8+ cytotoxic T-lymphocyte responses after genetic immunization with retrovirus vectors expressing different forms of the hepatitis B virus core and e antigens. J. Virol. 71, 3365-3674.
33. TRIPATHY, S.K., BLACK, H.B., GOLDWASSER, E., and LEIDEN, J.M. (1996). Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat. Med. 2, 545-550.
34. XIN, K.Q., URABE, M., YANG, J., NOMIYAMA, K., MIZUKAMI, H., HAMAJIMA, K., NOMIYAMA, H., SAITO, T., IMAI, M., MONAHAN, J., OKUDA, K., OZAWA, K., and OKUDA, K. (2001). A novel recombinant adeno-associated virus vaccine induces a long-term humoral immune response to human immunodeficiency virus. Hum. Gene Ther. 12, 1047-1061.
35. XU, L., DALY, T., GAO, C., FLOTTE, T.R., SONG, S., BYRNE, B.J., SANDS, M.S., and PARKER PONDER, K. (2001). CMV-beta-actin promoter directs higher expression from an adeno-associated viral vector in the liver than the cytomegalovirus or elongation factor 1 alpha promoter and results in therapeutic levels of human factor X in mice. Hum. Gene Ther. 12, 563-573.
36. XU, L., HASKINS, M.E., MELNICZEK, J.R., GAO, C., WEIL, M.A., O'MALLEY, T.M., O'DONNELL, P.A., MAZRIER, H., ELLINWOOD, N.M., ZWEIGLE, J., WOLFE, J.H., and PONDER, K.P. (2002). Transduction of hepatocytes after neonatal delivery of a Moloney murine leukemia virus based retroviral vector results in long-term expression of beta-glucuronidase in mucopolysaccharidosis VII dogs. Mol. Ther. 5, 141-153.
37. YANG, Y., ERTL, H.C., and WILSON, J.M. (1994). MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with El-deleted recombinant adenoviruses. Immunity 1, 433-442.
38. YANG, Y.P., LI, Q., ERTL, H.C.J., and WILSON, J.M. (1995). Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69, 2004-2015.
39. ZOLOTUKHIN, S., BYRNE, B.J., MASON, E., ZOLOTUKHIN, I., POTTER, M., CHESNUT, K., SUMMERFORD, C., SAMULSKI, R.J., and MUZYCZKA, N. (1999). Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther. 6, 973-985.